Global Diabetic Therapeutic Drugs Market Size, Status and Forecast 2022

December 2017 | 100 pages | ID: G10CEBF475CEN
QYResearch

Abstracts

This report studies the global Diabetic Therapeutic Drugs market, analyzes and researches the Diabetic Therapeutic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Pfizer
• Novartis
• AstraZeneca
• Eli Lilly
• Merck
• Novo Nordisk
• Sanofi
• F. Hoffmann-La Roche
• Takeda Pharmaceuticals
• Sun Pharma
• Perle Biosciences
• Arbutus Biopharma
• Belrose Pharma
• Mitsubishi Tanabe Pharma
• Dong-A ST
• Eisai

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Insulin Therapies
• Non-Insulin Therapies

Market segment by Application, Diabetic Therapeutic Drugs can be split into

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Diabetic Therapeutic Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF DIABETIC THERAPEUTIC DRUGS

1.1 Diabetic Therapeutic Drugs Market Overview
  1.1.1 Diabetic Therapeutic Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Diabetic Therapeutic Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Diabetic Therapeutic Drugs Market by Type
  1.3.1 Insulin Therapies
  1.3.2 Non-Insulin Therapies
1.4 Diabetic Therapeutic Drugs Market by End Users/Application
  1.4.1 Type 1 Diabetes
  1.4.2 Type 2 Diabetes
  1.4.3 Gestational Diabetes

2 GLOBAL DIABETIC THERAPEUTIC DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Diabetic Therapeutic Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Pfizer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Novartis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 AstraZeneca
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Eli Lilly
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Merck
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Novo Nordisk
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Sanofi
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 F. Hoffmann-La Roche
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Takeda Pharmaceuticals
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Sun Pharma
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Diabetic Therapeutic Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Perle Biosciences
3.12 Arbutus Biopharma
3.13 Belrose Pharma
3.14 Mitsubishi Tanabe Pharma
3.15 Dong-A ST
3.16 Eisai

4 GLOBAL DIABETIC THERAPEUTIC DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Diabetic Therapeutic Drugs Market Size by Type (2012-2017)
4.2 Global Diabetic Therapeutic Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Diabetic Therapeutic Drugs in Future
4.4 Top Consumer/End Users of Diabetic Therapeutic Drugs

5 UNITED STATES DIABETIC THERAPEUTIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Diabetic Therapeutic Drugs Market Size (2012-2017)
5.2 United States Diabetic Therapeutic Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU DIABETIC THERAPEUTIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Diabetic Therapeutic Drugs Market Size (2012-2017)
6.2 EU Diabetic Therapeutic Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN DIABETIC THERAPEUTIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Diabetic Therapeutic Drugs Market Size (2012-2017)
7.2 Japan Diabetic Therapeutic Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA DIABETIC THERAPEUTIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Diabetic Therapeutic Drugs Market Size (2012-2017)
8.2 China Diabetic Therapeutic Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA DIABETIC THERAPEUTIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Diabetic Therapeutic Drugs Market Size (2012-2017)
9.2 India Diabetic Therapeutic Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA DIABETIC THERAPEUTIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Diabetic Therapeutic Drugs Market Size (2012-2017)
10.2 Southeast Asia Diabetic Therapeutic Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Diabetic Therapeutic Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Diabetic Therapeutic Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Diabetic Therapeutic Drugs Market Size by Application (2017-2022)

12 DIABETIC THERAPEUTIC DRUGS MARKET DYNAMICS

12.1 Diabetic Therapeutic Drugs Market Opportunities
12.2 Diabetic Therapeutic Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Diabetic Therapeutic Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Diabetic Therapeutic Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Diabetic Therapeutic Drugs Product Scope
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) (2012-2017)
Table Global Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Diabetic Therapeutic Drugs Market Share by Regions in 2016
Figure United States Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Diabetic Therapeutic Drugs Market Share by Type in 2016
Figure Insulin Therapies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Non-Insulin Therapies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Diabetic Therapeutic Drugs Market Share by Application in 2016
Table Key Downstream Customer in Type 1 Diabetes
Figure Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate in Type 1 Diabetes (2012-2017)
Table Key Downstream Customer in Type 2 Diabetes
Figure Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate in Type 2 Diabetes (2012-2017)
Table Key Downstream Customer in Gestational Diabetes
Figure Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate in Gestational Diabetes (2012-2017)
Table Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Novo Nordisk Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Novo Nordisk (2012-2017)
Figure Novo Nordisk Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Takeda Pharmaceuticals Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Takeda Pharmaceuticals (2012-2017)
Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Sun Pharma Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Sun Pharma (2012-2017)
Figure Sun Pharma Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Perle Biosciences Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Perle Biosciences (2012-2017)
Figure Perle Biosciences Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Arbutus Biopharma Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Arbutus Biopharma (2012-2017)
Figure Arbutus Biopharma Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Belrose Pharma Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Belrose Pharma (2012-2017)
Figure Belrose Pharma Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Mitsubishi Tanabe Pharma Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Mitsubishi Tanabe Pharma (2012-2017)
Figure Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Dong-A ST Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Dong-A ST (2012-2017)
Figure Dong-A ST Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Eisai Basic Information List
Table Diabetic Therapeutic Drugs Business Revenue (Million USD) of Eisai (2012-2017)
Figure Eisai Diabetic Therapeutic Drugs Business Revenue Market Share in 2016
Table Global Diabetic Therapeutic Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2012
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2013
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2014
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2015
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2016
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2017
Table Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2012
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2013
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2014
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2015
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2016
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Diabetic Therapeutic Drugs
Figure United States Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure United States Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Figure EU Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure EU Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Figure Japan Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure Japan Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Figure China Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure China Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Figure India Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure India Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Figure Southeast Asia Diabetic Therapeutic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Diabetic Therapeutic Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Diabetic Therapeutic Drugs Market Size Share by Players in 2016
Figure Southeast Asia Diabetic Therapeutic Drugs Market Size Share by Players in 2017
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Diabetic Therapeutic Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Diabetic Therapeutic Drugs Market Size Share by Regions in 2017
Figure Global Diabetic Therapeutic Drugs Market Size Share by Regions in 2022
Figure United States Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Diabetic Therapeutic Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2017
Figure Global Diabetic Therapeutic Drugs Market Size Share by Type in 2022
Table Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2017
Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) by Application in 2022